[HTML][HTML] The international WAO/EAACI guideline for the management of hereditary angioedema–the 2021 revision and update
Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …
Summary and future of medicine for hereditary angioedema
L Ding, MJ Zhang, GW Rao - Drug discovery today, 2024 - Elsevier
Hereditary angioedema (HAE) is a rare autosomal genetic disease for which there are
currently nine FDA-approved drugs. This review summarizes drug treatments for HAE based …
currently nine FDA-approved drugs. This review summarizes drug treatments for HAE based …
Hereditary angioedema: a review of the current and evolving treatment landscape
SD Betschel, A Banerji, PJ Busse, DM Cohn… - The Journal of Allergy …, 2023 - Elsevier
Hereditary angioedema (HAE) is a rare disease characterized by sudden and often
unprovoked episodes of swelling that can be potentially life-threatening when it involves the …
unprovoked episodes of swelling that can be potentially life-threatening when it involves the …
[HTML][HTML] Lanadelumab in patients 2 to less than 12 years old with hereditary angioedema: results from the phase 3 SPRING study
M Maurer, WR Lumry, HH Li, E Aygören-Pürsün… - The Journal of Allergy …, 2024 - Elsevier
Background Symptoms of hereditary angioedema (HAE) often first occur during childhood,
and HAE attacks in children can be severe and substantially affect health-related quality of …
and HAE attacks in children can be severe and substantially affect health-related quality of …
[HTML][HTML] Treatment of hereditary angioedema—single or multiple pathways to the rescue
A Valerieva, HJ Longhurst - Frontiers in Allergy, 2022 - frontiersin.org
Hereditary angioedema (HAE) is a rare disease caused by mutations in the SERPING1
gene. This results in deficient or dysfunctional C1 esterase inhibitor (C1-INH) and affects …
gene. This results in deficient or dysfunctional C1 esterase inhibitor (C1-INH) and affects …
Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema
M Watt, M Malmenäs, D Romanus… - Journal of …, 2023 - becarispublishing.com
Aim: With no head-to-head studies comparing the effectiveness of lanadelumab and
berotralstat for prevention of hereditary angioedema (HAE) attacks, this network meta …
berotralstat for prevention of hereditary angioedema (HAE) attacks, this network meta …
Kallikrein inhibitors for angioedema: the progress of preclinical and early phase studies
H Farkas, Z Balla - Expert opinion on investigational drugs, 2024 - Taylor & Francis
Introduction Hereditary angioedema (HAE) is a rare genetic disorder characterized by
recurrent edema and predominantly caused by the dysregulation of the kinin-kallikrein …
recurrent edema and predominantly caused by the dysregulation of the kinin-kallikrein …
[HTML][HTML] Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedema
WR Lumry, M Maurer, K Weller, MA Riedl… - Annals of Allergy …, 2023 - Elsevier
Background Hereditary angioedema (HAE) is associated with a substantial disease burden.
Lanadelumab reduced the HAE attack rate during 132 weeks of follow-up in the HELP open …
Lanadelumab reduced the HAE attack rate during 132 weeks of follow-up in the HELP open …
Patient‐level indirect treatment comparison of lanadelumab versus pdC1‐INH iv in hereditary angioedema patients: PATCH study
M Magerl, G Schiffhorst, L Fanter, G Müller, C Hirche… - Allergy, 2024 - Wiley Online Library
Background Hereditary angioedema (HAE) is an autosomal dominant inherited disease in
which patients suffer from local attacks primarily affecting skin and gastrointestinal tract, and …
which patients suffer from local attacks primarily affecting skin and gastrointestinal tract, and …
Safety Aspects and Rational Use of Lanadelumab Injections in the Treatment of Hereditary Angioedema (HAE): Clinical Insights
E Petkova, V Yordanova, M Staevska… - Drug, Healthcare and …, 2022 - Taylor & Francis
Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent
episodes of skin/mucosal swelling, and/or attacks of severe abdominal pain when it affects …
episodes of skin/mucosal swelling, and/or attacks of severe abdominal pain when it affects …